Lajos Gera

3.5k total citations
106 papers, 2.8k citations indexed

About

Lajos Gera is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Lajos Gera has authored 106 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Genetics, 46 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Lajos Gera's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (64 papers), Peptidase Inhibition and Analysis (23 papers) and Chemical Synthesis and Analysis (22 papers). Lajos Gera is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (64 papers), Peptidase Inhibition and Analysis (23 papers) and Chemical Synthesis and Analysis (22 papers). Lajos Gera collaborates with scholars based in United States, Canada and Germany. Lajos Gera's co-authors include John M. Stewart, François Marceau, Daniel C. Chan, Fernando Alberício, George Bárány, Eric T. Whalley, Norbert F. Voelkel, Marie‐Thérèse Bawolak, John S. Zuzack and Robert S. Hodges and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Circulation Research.

In The Last Decade

Lajos Gera

106 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lajos Gera United States	29	1.3k	1.0k	533	528	434	106	2.8k
Brigitte Bauvois France	30	1.3k 1.0×	189 0.2×	192 0.4×	1.1k 2.1×	444 1.0×	90	3.0k
Kohji Hanasaki Japan	36	2.5k 1.9×	180 0.2×	216 0.4×	345 0.7×	686 1.6×	83	4.0k
Athan Kuliopulos United States	48	2.9k 2.2×	957 0.9×	275 0.5×	777 1.5×	626 1.4×	94	6.6k
Thomas Rückle Switzerland	30	1.8k 1.3×	501 0.5×	143 0.3×	581 1.1×	1.1k 2.4×	37	3.2k
Linda K. Jolliffe United States	31	1.5k 1.2×	220 0.2×	115 0.2×	780 1.5×	959 2.2×	60	3.7k
Richard Söll United States	23	1.2k 1.0×	609 0.6×	84 0.2×	402 0.8×	242 0.6×	75	2.7k
Dirk Hendriks Belgium	27	899 0.7×	208 0.2×	276 0.5×	753 1.4×	103 0.2×	96	2.5k
Jochen Knolle Germany	22	1.1k 0.9×	1.3k 1.3×	60 0.1×	310 0.6×	376 0.9×	57	2.6k
Clifford D. Wright United States	26	805 0.6×	147 0.1×	233 0.4×	134 0.3×	683 1.6×	62	2.5k
Marc‐Eric Halatsch Germany	34	1.5k 1.2×	745 0.7×	294 0.6×	768 1.5×	244 0.6×	109	2.9k

Countries citing papers authored by Lajos Gera

Since Specialization

Citations

This map shows the geographic impact of Lajos Gera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lajos Gera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lajos Gera more than expected).

Fields of papers citing papers by Lajos Gera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lajos Gera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lajos Gera. The network helps show where Lajos Gera may publish in the future.

Co-authorship network of co-authors of Lajos Gera

This figure shows the co-authorship network connecting the top 25 collaborators of Lajos Gera. A scholar is included among the top collaborators of Lajos Gera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lajos Gera. Lajos Gera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Rui, Xiaowei Ma, Lijuan Bai, et al.. (2021). Overcoming prostate cancer drug resistance with a novel organosilicon small molecule. Neoplasia. 23(12). 1261–1274. 7 indexed citations

Marceau, François, Hélène Bachelard, Johanne Bouthillier, et al.. (2020). Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. International Immunopharmacology. 82. 106305–106305. 85 indexed citations

Gera, Lajos, et al.. (2016). In Vivo Effects of Bradykinin B2 Receptor Agonists with Varying Susceptibility to Peptidases. Frontiers in Pharmacology. 6. 306–306. 11 indexed citations

Gera, Lajos, Dmytro Havrylyuk, Robert S. Hodges, et al.. (2014). Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compounds. Bioorganic & Medicinal Chemistry. 22(15). 3815–3823. 31 indexed citations

Tian, Wen, Xinguo Jiang, Rasa Tamošiūnienė, et al.. (2013). Blocking Macrophage Leukotriene B ₄ Prevents Endothelial Injury and Reverses Pulmonary Hypertension. Science Translational Medicine. 5(200). 200ra117–200ra117. 202 indexed citations

Gera, Lajos, Caroline Roy, & François Marceau. (2012). Bifunctional epitope-agonist ligands of the bradykinin B₂ receptor. Biological Chemistry. 394(3). 379–383. 6 indexed citations

Jiang, Ziqing, Adriana I. Vasil, Lajos Gera, Michael L. Vasil, & Robert S. Hodges. (2011). Rational Design of α‐Helical Antimicrobial Peptides to Target Gram‐negative Pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: Utilization of Charge, ‘Specificity Determinants,’ Total Hydrophobicity, Hydrophobe Type and Location as Design Parameters to Improve the Therapeutic Ratio. Chemical Biology & Drug Design. 77(4). 225–240. 110 indexed citations

Gera, Lajos, Caroline Roy, Marie‐Thérèse Bawolak, et al.. (2011). Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue. Pharmacological Research. 64(5). 528–534. 13 indexed citations

Gera, Lajos, et al.. (2009). N-(Fluorenyl-9-methoxycarbonyl)amino Acid Amide Derivatives as a New Class of Anti-cancer Agents. Advances in experimental medicine and biology. 611. 465–466. 3 indexed citations

10.

Yemelyanov, Alexander, et al.. (2008). Novel Steroid Receptor Phyto-Modulator Compound A Inhibits Growth and Survival of Prostate Cancer Cells. Cancer Research. 68(12). 4763–4773. 52 indexed citations

11.

Bawolak, Marie‐Thérèse, Lajos Gera, Johanne Bouthillier, et al.. (2008). A fluorescent version of the bradykinin B2 receptor antagonist B-9430: Pharmacological characterization and use in live cell imaging. Peptides. 29(9). 1626–1630. 12 indexed citations

12.

Bawolak, Marie‐Thérèse, Lajos Gera, Guillaume Morissette, John Stewart, & François Marceau. (2007). B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) Is an Inactivation-Resistant Agonist of the Bradykinin B2 Receptor Derived from the Peptide Antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): Pharmacologic Profile and Effective Induction of Receptor Degradation. Journal of Pharmacology and Experimental Therapeutics. 323(2). 534–546. 29 indexed citations

13.

Gera, Lajos, Jean‐Philippe Fortin, Albert Adam, John M. Stewart, & François Marceau. (2006). Discovery of a Dual-Function Peptide That Combines Aminopeptidase N Inhibition and Kinin B1 Receptor Antagonism. Journal of Pharmacology and Experimental Therapeutics. 317(1). 300–308. 15 indexed citations

14.

Stewart, John M., et al.. (2004). New Lung Cancer Drugs From Bradykinin Antagonists. CHEST Journal. 125(5). 148S–148S. 10 indexed citations

15.

Choe, Kang‐Hyeon, Laimute Taraseviciene‐Stewart, Robertas Scerbavicius, et al.. (2003). Methylprednisolone Causes Matrix Metalloproteinase–dependent Emphysema in Adult Rats. American Journal of Respiratory and Critical Care Medicine. 167(11). 1516–1521. 49 indexed citations

16.

Stewart, John M., Daniel C. Chan, Paul A. Bunn, et al.. (2002). Bradykinin antagonists as new drugs for prostate cancer. International Immunopharmacology. 2(13-14). 1781–1786. 20 indexed citations

17.

Stewart, John M., Lajos Gera, Daniel C. Chan, et al.. (2002). Bradykinin-related compounds as new drugs for cancer and inflammation. Canadian Journal of Physiology and Pharmacology. 80(4). 275–280. 41 indexed citations

18.

Pan, Weihong, Abba J. Kastin, Lajos Gera, & John Stewart. (2001). Bradykinin antagonist decreases early disruption of the blood–spinal cord barrier after spinal cord injury in mice. Neuroscience Letters. 307(1). 25–28. 30 indexed citations

19.

Reißmann, Siegmund, et al.. (2000). Structure activity relationships for bradykinin antagonists on the inhibition of cytokine release and the release of histamine☆. Peptides. 21(4). 527–533. 9 indexed citations

20.

Wieczorek, Maciej, Michael Burkard, John S. Zuzack, et al.. (1997). Bradykinin antagonists in human systems: Correlation between receptor binding, calcium signalling in isolated cells, and functional activity in isolated ileum. Biochemical Pharmacology. 54(2). 283–291. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact